X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (27663) 27663
Book Review (5134) 5134
Publication (2653) 2653
Newsletter (298) 298
Book / eBook (97) 97
Book Chapter (90) 90
Conference Proceeding (77) 77
Dissertation (16) 16
Magazine Article (11) 11
Web Resource (5) 5
Data Set (3) 3
Government Document (3) 3
Streaming Video (3) 3
Journal / eJournal (1) 1
Newspaper Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (26384) 26384
humans (23498) 23498
animals (13107) 13107
oncology (10625) 10625
female (9975) 9975
mice (8560) 8560
cancer (6243) 6243
cell line, tumor (5774) 5774
male (5722) 5722
antibodies, monoclonal - pharmacology (4871) 4871
antineoplastic agents - pharmacology (4369) 4369
pharmacology & pharmacy (4313) 4313
antibodies, monoclonal - therapeutic use (3957) 3957
tumor cells, cultured (3745) 3745
expression (3653) 3653
middle aged (3423) 3423
antibodies (3211) 3211
antineoplastic agents - therapeutic use (3134) 3134
monoclonal-antibody (3009) 3009
aged (2872) 2872
adult (2863) 2863
tumors (2805) 2805
immunology (2762) 2762
immunotherapy (2698) 2698
antibodies, monoclonal, humanized (2686) 2686
fluorescent antibody technique (2646) 2646
apoptosis (2602) 2602
chemotherapy (2567) 2567
monoclonal antibodies (2447) 2447
mice, nude (2429) 2429
research (2396) 2396
therapy (2311) 2311
neoplasms - drug therapy (2239) 2239
medicine, research & experimental (2171) 2171
antibodies, monoclonal - immunology (2104) 2104
apoptosis - drug effects (2101) 2101
cell biology (2086) 2086
mice, inbred balb c (2054) 2054
care and treatment (2036) 2036
cell proliferation - drug effects (1999) 1999
xenograft model antitumor assays (1989) 1989
blotting, western (1976) 1976
treatment outcome (1957) 1957
biochemistry & molecular biology (1949) 1949
breast cancer (1915) 1915
breast neoplasms - drug therapy (1907) 1907
proteins (1844) 1844
trastuzumab (1821) 1821
flow cytometry (1811) 1811
metastasis (1786) 1786
breast neoplasms - pathology (1721) 1721
immunohistochemistry (1705) 1705
cells (1692) 1692
antineoplastic combined chemotherapy protocols - therapeutic use (1661) 1661
antibodies, monoclonal - administration & dosage (1652) 1652
cell line (1648) 1648
neoplasms - immunology (1615) 1615
health aspects (1610) 1610
article (1609) 1609
monoclonal-antibodies (1589) 1589
neoplasm transplantation (1585) 1585
in-vivo (1574) 1574
analysis (1549) 1549
rats (1523) 1523
breast-cancer (1517) 1517
signal transduction (1484) 1484
abridged index medicus (1479) 1479
signal transduction - drug effects (1444) 1444
bevacizumab (1414) 1414
breast neoplasms - metabolism (1409) 1409
carcinoma (1393) 1393
angiogenesis (1326) 1326
dose-response relationship, drug (1315) 1315
activation (1307) 1307
drug resistance, neoplasm (1283) 1283
antibody (1279) 1279
cetuximab (1243) 1243
gene expression (1204) 1204
antigens, neoplasm - immunology (1202) 1202
drug therapy (1199) 1199
medicine & public health (1199) 1199
hematology (1179) 1179
neoplasms - therapy (1177) 1177
growth (1166) 1166
in-vitro (1161) 1161
neoplasm metastasis (1158) 1158
cells, cultured (1156) 1156
phosphorylation (1145) 1145
growth-factor receptor (1142) 1142
time factors (1127) 1127
clinical trials as topic (1106) 1106
antibodies, monoclonal - adverse effects (1104) 1104
prognosis (1099) 1099
neoplasms - metabolism (1096) 1096
antibodies, monoclonal (1093) 1093
cell division - drug effects (1087) 1087
neoplasms - pathology (1083) 1083
multidisciplinary sciences (1081) 1081
medicine (1059) 1059
antineoplastic agents - administration & dosage (1040) 1040
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (59) 59
Online Resources - Online (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (4) 4
Engineering & Comp. Sci. - Stacks (3) 3
Earth Sciences (Noranda) - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Toronto East General Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (27497) 27497
Chinese (179) 179
Japanese (136) 136
Russian (70) 70
German (66) 66
French (64) 64
Spanish (25) 25
Italian (19) 19
Polish (15) 15
Hungarian (12) 12
Czech (4) 4
Finnish (4) 4
Hebrew (3) 3
Dutch (2) 2
Norwegian (2) 2
Korean (1) 1
Portuguese (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Biotechnology, ISSN 1087-0156, 08/2008, Volume 26, Issue 8, pp. 925 - 932
Journal Article
Cell Reports, ISSN 2211-1247, 05/2016, Volume 15, Issue 9, pp. 2000 - 2011
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4476 - 4481
Inhibition of the vascular endothelial growth factor (VEGF) pathway has failed to improve overall survival of patients with glioblastoma (GBM). We previously... 
Anti-angiogenic therapy | Macrophage polarization | Tumor microenvironment | Microglia reprogramming | Anti-tumor immunity | anti-angiogenic therapy | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | macrophage polarization | RANDOMIZED-TRIAL | ANGIOPOIETIN-2 | CANCER | THERAPY | microglia reprogramming | TIE2-EXPRESSING MONOCYTES | BLOOD-VESSELS | TUMOR-ASSOCIATED MACROPHAGES | tumor microenvironment | NORMALIZATION | anti-tumor immunity | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Antibodies, Bispecific - pharmacology | Vesicular Transport Proteins - metabolism | Humans | Neoplasm Proteins - antagonists & inhibitors | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neoplasms, Experimental - pathology | Xenograft Model Antitumor Assays | Macrophages - metabolism | Vesicular Transport Proteins - antagonists & inhibitors | Animals | Antibodies, Neoplasm - pharmacology | Ribonuclease, Pancreatic - metabolism | Glioblastoma - pathology | Cell Line, Tumor | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Mice | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Viral antibodies | Care and treatment | Antibodies | Physiological aspects | Models | Macrophages | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Genotype & phenotype | Survival analysis | Protein expression | Cells | Tumors | Cancer | Index Medicus | Biological Sciences
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 2013, Volume 210, Issue 9, pp. 1685 - 1693
Fc gamma receptor (Fc gamma R) coengagement can facilitate antibody-mediated receptor activation in target cells. In particular, agonistic antibodies that... 
MEDICINE, RESEARCH & EXPERIMENTAL | RESPONSES | MELANOMA | ANTI-GITR MAB | REGULATORY T-CELLS | COSTIMULATION | IGG1 | CANCER-IMMUNOTHERAPY | IMMUNOLOGY | BLOCKADE | BINDING | TUMOR-IMMUNITY | Index Medicus | Brief Definitive Report
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2015, Volume 112, Issue 9, pp. E966 - E972
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2016, Volume 113, Issue 16, pp. 4470 - 4475
Glioblastomas (GBMs) rapidly become refractory to anti-VEGF therapies. We previously demonstrated that ectopic overexpression of angiopoietin-2 (Ang-2)... 
Anti-angiogenic therapy | Colony-stimulating factor 1 | Tumor immunity | Tumor microenvironment | Macrophage | anti-angiogenic therapy | ANGIOPOIETIN-2 FUNCTIONS | ANGIOGENESIS | MULTIDISCIPLINARY SCIENCES | macrophage | BEVACIZUMAB PLUS IRINOTECAN | RANDOMIZED-TRIAL | ANTIBODY | tumor immunity | KINASE INHIBITOR | ANTIANGIOGENIC THERAPY | PHASE-II TRIAL | colony-stimulating factor 1 | tumor microenvironment | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Macrophages - pathology | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Neovascularization, Pathologic - pathology | Neoplasms, Experimental - pathology | Macrophages - metabolism | Animals | Antibodies, Neoplasm - pharmacology | Receptors, Vascular Endothelial Growth Factor - metabolism | Ribonuclease, Pancreatic - metabolism | Neovascularization, Pathologic - drug therapy | Glioblastoma - pathology | Cell Line, Tumor | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Glioblastoma - metabolism | Mice | Neovascularization, Pathologic - metabolism | Neoplasms, Experimental - metabolism | Glioblastoma - drug therapy | Quinazolines - pharmacology | Ribonuclease, Pancreatic - antagonists & inhibitors | Neoplasms, Experimental - drug therapy | Drug Screening Assays, Antitumor | Survival analysis | Gene expression | Kinases | Cells | Tumors | Cancer | Index Medicus | Biological Sciences
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2016, Volume 126, Issue 5, pp. 1885 - 1896
Recent studies in patients with ovarian cancer suggest that tumor growth may be accelerated following cessation of antiangiogenesis therapy; however, the... 
Blood Platelets - pathology | Focal Adhesion Kinase 1 - genetics | Bevacizumab - pharmacology | Humans | Ovarian Neoplasms - pathology | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Neovascularization, Pathologic - pathology | Ovarian Neoplasms - genetics | Neovascularization, Pathologic - enzymology | Antibodies, Neoplasm - pharmacology | Tumor Microenvironment - genetics | Female | Neoplasm Proteins - genetics | Focal Adhesion Kinase 1 - metabolism | Ovarian Neoplasms - drug therapy | Tumor Microenvironment - drug effects | Cell Hypoxia - drug effects | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Ovarian Neoplasms - enzymology | Mice, Knockout | Xenograft Model Antitumor Assays | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Neovascularization, Pathologic - genetics | Mice | Adenosine Diphosphate - metabolism | Cell Hypoxia - genetics | Focal Adhesion Kinase 1 - antagonists & inhibitors | Antimitotic agents | Care and treatment | Analysis | Development and progression | Dosage and administration | Antineoplastic agents | Vascular endothelial growth factor | Health aspects | Ovarian cancer | Medical research | Cell culture | Cytokines | Clinical trials | Metastasis | Grants | Experiments | Cancer therapies | Studies | Disease prevention | Microscopy | Hypoxia | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 03/2013, Volume 110, Issue 12, pp. E1083 - E1091
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 07/2006, Volume 21, Issue 7, pp. 1045 - 1059
The role of CTGF/CCN2 in osteolytic metastasis by breast cancer cells and its mechanism of action were studied. Osteolytic metastasis accompanied by CCN2 and... 
connective tissue growth factor | PTH‐related peptide | extracellular signal‐regulated kinase | mitogen‐activated protein kinase | bone resorption | Bone resorption | PTH-related peptide | Extracellular signal-regulated kinase | Mitogen-activated protein kinase | Connective tissue growth factor | NUDE-MICE | extracellular signal-regulated kinase | CHONDROCYTE-SPECIFIC GENE | OSTEOBLAST-LIKE CELLS | mitogen-activated protein kinase | HORMONE-RELATED PROTEIN | ANGIOGENESIS IN-VIVO | ENDOCRINOLOGY & METABOLISM | HUMANIZED MONOCLONAL-ANTIBODY | PARATHYROID-HORMONE | BONE METASTASIS | VASCULAR ENDOTHELIAL-CELLS | OSTEOTROPIC HORMONES | Protein Kinases - metabolism | Neoplasm Transplantation | Humans | Bone Neoplasms - secondary | Intercellular Signaling Peptides and Proteins - biosynthesis | Neoplasm Proteins - antagonists & inhibitors | Bone Neoplasms - pathology | Bone Neoplasms - metabolism | Breast Neoplasms - metabolism | Parathyroid Hormone-Related Protein - biosynthesis | Neoplasms, Experimental - pathology | Neoplasm Metastasis | Antibodies, Neoplasm - pharmacology | Drug Design | Female | Bone Neoplasms - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Osteolysis - pathology | Signal Transduction | Neoplasm Proteins - biosynthesis | Antibodies, Monoclonal - pharmacology | Immediate-Early Proteins - biosynthesis | Breast Neoplasms - drug therapy | Osteolysis - metabolism | Animals | Breast Neoplasms - pathology | Cell Line, Tumor | Mice | Neoplasms, Experimental - metabolism | Neoplasms, Experimental - drug therapy | Immediate-Early Proteins - antagonists & inhibitors | Connective Tissue Growth Factor | Index Medicus
Journal Article